According to OPKO Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.77778. At the end of 2022 the company had a P/E ratio of -2.84.
Year | P/E ratio | Change |
---|---|---|
2022 | -2.84 | -97.05% |
2021 | -96.2 | -221.77% |
2020 | 79.0 | -2948.3% |
2019 | -2.77 | -75.12% |
2018 | -11.1 | 20.58% |
2017 | -9.25 | -96.02% |
2016 | -233 | 101.42% |
2015 | -115 | 362.19% |
2014 | -25.0 | -5.31% |
2013 | -26.4 | -39.68% |
2012 | -43.7 | |
2010 | -45.9 | 301.09% |
2009 | -11.4 | 48.26% |
2008 | -7.71 | 928.57% |
2007 | -0.7500 | -96.19% |
2006 | -19.7 | 44.15% |
2005 | -13.7 | 382.35% |
2004 | -2.83 | 19.63% |
2003 | -2.37 | 346.62% |
2002 | -0.5303 | -90.92% |
2001 | -5.84 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.